Arizona's Vision Eye Care Center
Mon-Thu: 9:00AM - 6:00PM Friday: 8:00AM- 5:00PM
15215 S. 48th Street #180 Phoenix, AZ 85044
New dry eye treatments — including Intense Pulsed Light therapy, thermal pulsation devices, and prescription biologics — now target the root causes of dry eye disease rather than just masking symptoms. These advances have changed what patients in Phoenix, AZ can expect from dry eye care, offering longer-lasting relief than traditional artificial tears alone.
Dry eye affects millions of Americans, and for many patients, over-the-counter drops simply are not enough to manage daily discomfort.
This guide explains the newest clinical treatments available, how doctors choose the right option for each patient, and what to expect when you seek care at Arizona's Vision Eye Care Center.

Dry eye disease is a chronic condition in which the eyes either do not produce enough tears or produce tears that evaporate too quickly. The result is persistent irritation, burning, blurred vision, and in some cases, damage to the surface of the eye.
There are two primary types. Aqueous-deficient dry eye occurs when the lacrimal glands do not produce sufficient tear volume. Evaporative dry eye — the more common form, accounting for the majority of cases — occurs when the meibomian glands along the eyelid margins become blocked or dysfunctional, causing the oily layer of the tear film to break down too quickly.
Understanding which type you have is essential, because the newest treatments are designed to address specific causes rather than provide temporary surface relief. Dry eye is a chronic condition with a range of causes and severity levels — our dry eye treatment options page covers the full spectrum of care available at Arizona's Vision Eye Care Center, from lifestyle adjustments to advanced clinical therapies.
The most significant shift in dry eye care over the past several years has been the move from symptom management to root-cause treatment. Several FDA-cleared therapies and prescription options are now available that address the underlying dysfunction driving chronic dry eye.
IPL therapy uses controlled pulses of light applied to the skin around the eyes to reduce inflammation in the meibomian glands and improve their function. Originally developed for dermatology, IPL has been adapted for dry eye care and is particularly effective for patients with evaporative dry eye caused by meibomian gland dysfunction (MGD).
Treatment typically involves a series of sessions spaced several weeks apart. Patients often notice improvement in tear film stability and a reduction in symptoms after completing the initial series. Intense Pulsed Light therapy targets the root cause of evaporative dry eye by reducing inflammation in the meibomian glands — our dedicated IPL therapy for dry eyes page explains the full procedure, candidacy criteria, and what patients in Phoenix can expect during treatment.
LipiFlow is an FDA-cleared in-office device that applies precisely controlled heat to the inner eyelids while simultaneously delivering gentle pulsatile pressure to the outer lids. This combination liquefies and expresses the thickened, blocked secretions inside the meibomian glands, restoring their ability to produce the oily layer of the tear film.
The procedure takes approximately 12 minutes per eye and is performed in a single office visit. Clinical studies have shown meaningful improvement in meibomian gland function and symptom scores for patients with MGD. LipiFlow uses controlled heat and gentle pressure to clear blocked meibomian glands in a single in-office session — our LipiFlow thermal pulsation page details how this FDA-cleared device works and which patients benefit most.
Neurostimulation is one of the newer approaches to dry eye management. Devices such as the iTear100 stimulate the external nasal nerve using gentle oscillatory energy, triggering the body's natural tear production pathway without the use of drugs or drops. This approach is particularly useful for patients with aqueous-deficient dry eye who have not responded well to other therapies.
The device is small, handheld, and designed for patient use at home, making it a practical option for ongoing management between clinical visits.
Several prescription therapies now target the inflammatory component of dry eye disease at the cellular level. Cyclosporine-based drops such as Restasis and Cequa work by suppressing the immune-mediated inflammation that damages tear-producing cells. Lifitegrast (Xiidra) blocks a specific protein involved in the inflammatory cycle on the ocular surface.
More recently, varenicline nasal spray (Tyrvaya) has been approved as a neurostimulatory prescription option that increases natural tear production through the trigeminal parasympathetic pathway. These prescription options require a clinical evaluation and ongoing monitoring to assess effectiveness and tolerability.
No single treatment works for every patient. The selection process begins with a comprehensive diagnostic evaluation that identifies the type and severity of dry eye, the degree of meibomian gland dysfunction, and the condition of the ocular surface.
Diagnostic tools used in a thorough dry eye evaluation include tear osmolarity testing, meibography (imaging of the meibomian glands), tear breakup time assessment, and evaluation of the corneal and conjunctival surface. These findings, combined with your symptom history and lifestyle factors, allow your eye doctor to build a treatment plan matched to your specific condition.
For patients with mild dry eye, prescription drops or lifestyle modifications may be sufficient. For those with moderate to severe MGD, in-office procedures such as IPL or LipiFlow are often recommended. Patients with aqueous-deficient dry eye may benefit more from neurostimulation or cyclosporine-based therapies. Selecting the right dry eye therapy begins with a thorough diagnostic evaluation — scheduling a comprehensive eye exam at Arizona's Vision Eye Care Center gives your doctor the clinical data needed to match you with the most effective treatment.
Many patients manage mild dryness with over-the-counter artificial tears for months or years before seeking professional care. However, there are clear signs that your symptoms warrant a clinical evaluation rather than continued self-management.
You should schedule an appointment if you experience burning, stinging, or a gritty sensation that does not improve with drops, if your vision fluctuates or blurs throughout the day, if your eyes are frequently red or sensitive to light, or if dryness is interfering with your ability to wear contact lenses comfortably. Symptoms that worsen in dry or windy environments, or after extended screen use, are also common indicators of meibomian gland dysfunction that responds well to the newer in-office treatments.
Persistent dryness, burning, or blurred vision are signs that warrant professional evaluation — our eye conditions we treat page outlines the full range of conditions managed at Arizona's Vision Eye Care Center, helping you understand when symptoms require clinical attention.
Early evaluation matters because untreated dry eye can progress. Chronic inflammation on the ocular surface can damage the corneal epithelium over time, and meibomian glands that remain blocked for extended periods can undergo permanent structural changes that reduce their ability to function.
A dry eye evaluation at Arizona's Vision Eye Care Center is a structured, diagnostic appointment — not simply a routine eye exam. Your provider will review your symptom history, current medications (many of which contribute to dry eye), and any previous treatments you have tried.
Diagnostic testing will assess your tear film quality, tear production volume, and the health of your meibomian glands. Meibography, when available, provides direct imaging of the gland structure and can identify atrophy or dropout that explains why symptoms have been difficult to control.
Based on your results, your provider will explain which treatment options are appropriate for your condition, what the expected timeline for improvement looks like, and how to monitor your response. For patients who wear contact lenses, your evaluation will also address lens compatibility — our contact lenses for dry eyes page explains which lens types and care routines work best for dry eye patients.
Understanding which provider manages your dry eye care is an important part of your evaluation — our optometrist vs ophthalmologist guide explains the difference in roles and helps you know what level of care your condition requires.
Dry eye disease is no longer a condition patients simply have to live with. Advances in IPL therapy, thermal pulsation, neurostimulation, and prescription biologics have created a new standard of care that addresses the root causes of chronic dry eye rather than masking symptoms.
The right treatment depends on your specific diagnosis — the type of dry eye, the degree of gland dysfunction, and how your ocular surface has responded to previous care.
At Arizona's Vision Eye Care Center in Phoenix, our team is ready to evaluate your symptoms, identify the underlying cause, and guide you toward the treatment that gives you the best chance of lasting relief. Contact us today to schedule your dry eye evaluation.
IPL therapy for dry eyes is generally considered an elective procedure and is not covered by most insurance plans. Costs vary by provider and the number of sessions required. Your eye doctor can provide a cost estimate during your evaluation.
Results vary by treatment type. Prescription drops such as cyclosporine may take 3–6 months to show full effect. In-office procedures like LipiFlow and IPL often produce noticeable improvement within 4–8 weeks after the initial treatment series is complete.
Dry eye disease is typically a chronic condition that requires ongoing management rather than a one-time cure. However, newer treatments can significantly reduce symptoms and slow disease progression, allowing many patients to achieve long-term comfort with periodic maintenance care.
FDA-cleared devices such as LipiFlow and IPL systems approved for dry eye use have established safety profiles supported by clinical studies. Prescription medications are monitored by your eye doctor for effectiveness and tolerability. Your provider will review your candidacy before recommending any treatment.
Artificial tears provide temporary surface lubrication but do not address the underlying cause of dry eye. Prescription treatments such as cyclosporine drops or in-office procedures target the inflammation or gland dysfunction driving the condition, offering longer-lasting improvement for patients with moderate to severe disease.
Yes. Dry eye can affect children, particularly those with high screen time, allergies, or certain medical conditions. If your child complains of eye irritation, frequent blinking, or difficulty with reading or screen use, a pediatric eye evaluation is recommended.
In most cases, you do not need a referral to schedule a dry eye evaluation with an optometrist. Arizona's Vision Eye Care Center accepts patients directly. If your condition requires surgical intervention or specialty care, your optometrist will coordinate a referral to an ophthalmologist.
New dry eye treatments — including Intense Pulsed Light therapy, thermal pulsation devices, and prescription biologics — now target the root causes of dry eye disease rather than just masking symptoms. These advances have changed what patients in Phoenix, AZ can expect from dry eye care, offering longer-lasting relief than traditional artificial tears alone.
Dry eye affects millions of Americans, and for many patients, over-the-counter drops simply are not enough to manage daily discomfort.
This guide explains the newest clinical treatments available, how doctors choose the right option for each patient, and what to expect when you seek care at Arizona's Vision Eye Care Center.
Dry eye disease is a chronic condition in which the eyes either do not produce enough tears or produce tears that evaporate too quickly. The result is persistent irritation, burning, blurred vision, and in some cases, damage to the surface of the eye.
There are two primary types. Aqueous-deficient dry eye occurs when the lacrimal glands do not produce sufficient tear volume. Evaporative dry eye — the more common form, accounting for the majority of cases — occurs when the meibomian glands along the eyelid margins become blocked or dysfunctional, causing the oily layer of the tear film to break down too quickly.
Understanding which type you have is essential, because the newest treatments are designed to address specific causes rather than provide temporary surface relief. Dry eye is a chronic condition with a range of causes and severity levels — our dry eye treatment options page covers the full spectrum of care available at Arizona's Vision Eye Care Center, from lifestyle adjustments to advanced clinical therapies.
The most significant shift in dry eye care over the past several years has been the move from symptom management to root-cause treatment. Several FDA-cleared therapies and prescription options are now available that address the underlying dysfunction driving chronic dry eye.
IPL therapy uses controlled pulses of light applied to the skin around the eyes to reduce inflammation in the meibomian glands and improve their function. Originally developed for dermatology, IPL has been adapted for dry eye care and is particularly effective for patients with evaporative dry eye caused by meibomian gland dysfunction (MGD).
Treatment typically involves a series of sessions spaced several weeks apart. Patients often notice improvement in tear film stability and a reduction in symptoms after completing the initial series. Intense Pulsed Light therapy targets the root cause of evaporative dry eye by reducing inflammation in the meibomian glands — our dedicated IPL therapy for dry eyes page explains the full procedure, candidacy criteria, and what patients in Phoenix can expect during treatment. <!–NEW PAGE NEEDED–>
LipiFlow is an FDA-cleared in-office device that applies precisely controlled heat to the inner eyelids while simultaneously delivering gentle pulsatile pressure to the outer lids. This combination liquefies and expresses the thickened, blocked secretions inside the meibomian glands, restoring their ability to produce the oily layer of the tear film.
The procedure takes approximately 12 minutes per eye and is performed in a single office visit. Clinical studies have shown meaningful improvement in meibomian gland function and symptom scores for patients with MGD. LipiFlow uses controlled heat and gentle pressure to clear blocked meibomian glands in a single in-office session — our LipiFlow thermal pulsation page details how this FDA-cleared device works and which patients benefit most. <!–NEW PAGE NEEDED–>
Neurostimulation is one of the newer approaches to dry eye management. Devices such as the iTear100 stimulate the external nasal nerve using gentle oscillatory energy, triggering the body's natural tear production pathway without the use of drugs or drops. This approach is particularly useful for patients with aqueous-deficient dry eye who have not responded well to other therapies.
The device is small, handheld, and designed for patient use at home, making it a practical option for ongoing management between clinical visits.
Several prescription therapies now target the inflammatory component of dry eye disease at the cellular level. Cyclosporine-based drops such as Restasis and Cequa work by suppressing the immune-mediated inflammation that damages tear-producing cells. Lifitegrast (Xiidra) blocks a specific protein involved in the inflammatory cycle on the ocular surface.
More recently, varenicline nasal spray (Tyrvaya) has been approved as a neurostimulatory prescription option that increases natural tear production through the trigeminal parasympathetic pathway. These prescription options require a clinical evaluation and ongoing monitoring to assess effectiveness and tolerability.
No single treatment works for every patient. The selection process begins with a comprehensive diagnostic evaluation that identifies the type and severity of dry eye, the degree of meibomian gland dysfunction, and the condition of the ocular surface.
Diagnostic tools used in a thorough dry eye evaluation include tear osmolarity testing, meibography (imaging of the meibomian glands), tear breakup time assessment, and evaluation of the corneal and conjunctival surface. These findings, combined with your symptom history and lifestyle factors, allow your eye doctor to build a treatment plan matched to your specific condition.
For patients with mild dry eye, prescription drops or lifestyle modifications may be sufficient. For those with moderate to severe MGD, in-office procedures such as IPL or LipiFlow are often recommended. Patients with aqueous-deficient dry eye may benefit more from neurostimulation or cyclosporine-based therapies. Selecting the right dry eye therapy begins with a thorough diagnostic evaluation — scheduling a comprehensive eye exam at Arizona's Vision Eye Care Center gives your doctor the clinical data needed to match you with the most effective treatment.
Many patients manage mild dryness with over-the-counter artificial tears for months or years before seeking professional care. However, there are clear signs that your symptoms warrant a clinical evaluation rather than continued self-management.
You should schedule an appointment if you experience burning, stinging, or a gritty sensation that does not improve with drops, if your vision fluctuates or blurs throughout the day, if your eyes are frequently red or sensitive to light, or if dryness is interfering with your ability to wear contact lenses comfortably. Symptoms that worsen in dry or windy environments, or after extended screen use, are also common indicators of meibomian gland dysfunction that responds well to the newer in-office treatments.
Persistent dryness, burning, or blurred vision are signs that warrant professional evaluation — our eye conditions we treat page outlines the full range of conditions managed at Arizona's Vision Eye Care Center, helping you understand when symptoms require clinical attention.
Early evaluation matters because untreated dry eye can progress. Chronic inflammation on the ocular surface can damage the corneal epithelium over time, and meibomian glands that remain blocked for extended periods can undergo permanent structural changes that reduce their ability to function.
A dry eye evaluation at Arizona's Vision Eye Care Center is a structured, diagnostic appointment — not simply a routine eye exam. Your provider will review your symptom history, current medications (many of which contribute to dry eye), and any previous treatments you have tried.
Diagnostic testing will assess your tear film quality, tear production volume, and the health of your meibomian glands. Meibography, when available, provides direct imaging of the gland structure and can identify atrophy or dropout that explains why symptoms have been difficult to control.
Based on your results, your provider will explain which treatment options are appropriate for your condition, what the expected timeline for improvement looks like, and how to monitor your response. For patients who wear contact lenses, your evaluation will also address lens compatibility — our contact lenses for dry eyes page explains which lens types and care routines work best for dry eye patients. <!–NEW PAGE NEEDED–>
Understanding which provider manages your dry eye care is an important part of your evaluation — our optometrist vs ophthalmologist guide explains the difference in roles and helps you know what level of care your condition requires.
Dry eye disease is no longer a condition patients simply have to live with. Advances in IPL therapy, thermal pulsation, neurostimulation, and prescription biologics have created a new standard of care that addresses the root causes of chronic dry eye rather than masking symptoms.
The right treatment depends on your specific diagnosis — the type of dry eye, the degree of gland dysfunction, and how your ocular surface has responded to previous care.
At Arizona's Vision Eye Care Center in Phoenix, our team is ready to evaluate your symptoms, identify the underlying cause, and guide you toward the treatment that gives you the best chance of lasting relief. Contact us today to schedule your dry eye evaluation.
IPL therapy for dry eyes is generally considered an elective procedure and is not covered by most insurance plans. Costs vary by provider and the number of sessions required. Your eye doctor can provide a cost estimate during your evaluation.
Results vary by treatment type. Prescription drops such as cyclosporine may take 3–6 months to show full effect. In-office procedures like LipiFlow and IPL often produce noticeable improvement within 4–8 weeks after the initial treatment series is complete.
Dry eye disease is typically a chronic condition that requires ongoing management rather than a one-time cure. However, newer treatments can significantly reduce symptoms and slow disease progression, allowing many patients to achieve long-term comfort with periodic maintenance care.
FDA-cleared devices such as LipiFlow and IPL systems approved for dry eye use have established safety profiles supported by clinical studies. Prescription medications are monitored by your eye doctor for effectiveness and tolerability. Your provider will review your candidacy before recommending any treatment.
Artificial tears provide temporary surface lubrication but do not address the underlying cause of dry eye. Prescription treatments such as cyclosporine drops or in-office procedures target the inflammation or gland dysfunction driving the condition, offering longer-lasting improvement for patients with moderate to severe disease.
Yes. Dry eye can affect children, particularly those with high screen time, allergies, or certain medical conditions. If your child complains of eye irritation, frequent blinking, or difficulty with reading or screen use, a pediatric eye evaluation is recommended.
In most cases, you do not need a referral to schedule a dry eye evaluation with an optometrist. Arizona's Vision Eye Care Center accepts patients directly. If your condition requires surgical intervention or specialty care, your optometrist will coordinate a referral to an ophthalmologist.
New dry eye treatments — including Intense Pulsed Light therapy, thermal pulsation devices, and prescription biologics — now target the root causes of dry eye disease rather than just masking symptoms. These advances have changed what patients in Phoenix, AZ can expect from dry eye care, offering longer-lasting relief than traditional artificial tears alone.
Dry eye affects millions of Americans, and for many patients, over-the-counter drops simply are not enough to manage daily discomfort.
This guide explains the newest clinical treatments available, how doctors choose the right option for each patient, and what to expect when you seek care at Arizona's Vision Eye Care Center.
Dry eye disease is a chronic condition in which the eyes either do not produce enough tears or produce tears that evaporate too quickly. The result is persistent irritation, burning, blurred vision, and in some cases, damage to the surface of the eye.
There are two primary types. Aqueous-deficient dry eye occurs when the lacrimal glands do not produce sufficient tear volume. Evaporative dry eye — the more common form, accounting for the majority of cases — occurs when the meibomian glands along the eyelid margins become blocked or dysfunctional, causing the oily layer of the tear film to break down too quickly.
Understanding which type you have is essential, because the newest treatments are designed to address specific causes rather than provide temporary surface relief. Dry eye is a chronic condition with a range of causes and severity levels — our dry eye treatment options page covers the full spectrum of care available at Arizona's Vision Eye Care Center, from lifestyle adjustments to advanced clinical therapies.
The most significant shift in dry eye care over the past several years has been the move from symptom management to root-cause treatment. Several FDA-cleared therapies and prescription options are now available that address the underlying dysfunction driving chronic dry eye.
IPL therapy uses controlled pulses of light applied to the skin around the eyes to reduce inflammation in the meibomian glands and improve their function. Originally developed for dermatology, IPL has been adapted for dry eye care and is particularly effective for patients with evaporative dry eye caused by meibomian gland dysfunction (MGD).
Treatment typically involves a series of sessions spaced several weeks apart. Patients often notice improvement in tear film stability and a reduction in symptoms after completing the initial series. Intense Pulsed Light therapy targets the root cause of evaporative dry eye by reducing inflammation in the meibomian glands — our dedicated IPL therapy for dry eyes page explains the full procedure, candidacy criteria, and what patients in Phoenix can expect during treatment.
LipiFlow is an FDA-cleared in-office device that applies precisely controlled heat to the inner eyelids while simultaneously delivering gentle pulsatile pressure to the outer lids. This combination liquefies and expresses the thickened, blocked secretions inside the meibomian glands, restoring their ability to produce the oily layer of the tear film.
The procedure takes approximately 12 minutes per eye and is performed in a single office visit. Clinical studies have shown meaningful improvement in meibomian gland function and symptom scores for patients with MGD. LipiFlow uses controlled heat and gentle pressure to clear blocked meibomian glands in a single in-office session — our LipiFlow thermal pulsation page details how this FDA-cleared device works and which patients benefit most.
Neurostimulation is one of the newer approaches to dry eye management. Devices such as the iTear100 stimulate the external nasal nerve using gentle oscillatory energy, triggering the body's natural tear production pathway without the use of drugs or drops. This approach is particularly useful for patients with aqueous-deficient dry eye who have not responded well to other therapies.
The device is small, handheld, and designed for patient use at home, making it a practical option for ongoing management between clinical visits.
Several prescription therapies now target the inflammatory component of dry eye disease at the cellular level. Cyclosporine-based drops such as Restasis and Cequa work by suppressing the immune-mediated inflammation that damages tear-producing cells. Lifitegrast (Xiidra) blocks a specific protein involved in the inflammatory cycle on the ocular surface.
More recently, varenicline nasal spray (Tyrvaya) has been approved as a neurostimulatory prescription option that increases natural tear production through the trigeminal parasympathetic pathway. These prescription options require a clinical evaluation and ongoing monitoring to assess effectiveness and tolerability.
No single treatment works for every patient. The selection process begins with a comprehensive diagnostic evaluation that identifies the type and severity of dry eye, the degree of meibomian gland dysfunction, and the condition of the ocular surface.
Diagnostic tools used in a thorough dry eye evaluation include tear osmolarity testing, meibography (imaging of the meibomian glands), tear breakup time assessment, and evaluation of the corneal and conjunctival surface. These findings, combined with your symptom history and lifestyle factors, allow your eye doctor to build a treatment plan matched to your specific condition.
For patients with mild dry eye, prescription drops or lifestyle modifications may be sufficient. For those with moderate to severe MGD, in-office procedures such as IPL or LipiFlow are often recommended. Patients with aqueous-deficient dry eye may benefit more from neurostimulation or cyclosporine-based therapies. Selecting the right dry eye therapy begins with a thorough diagnostic evaluation — scheduling a comprehensive eye exam at Arizona's Vision Eye Care Center gives your doctor the clinical data needed to match you with the most effective treatment.
Many patients manage mild dryness with over-the-counter artificial tears for months or years before seeking professional care. However, there are clear signs that your symptoms warrant a clinical evaluation rather than continued self-management.
You should schedule an appointment if you experience burning, stinging, or a gritty sensation that does not improve with drops, if your vision fluctuates or blurs throughout the day, if your eyes are frequently red or sensitive to light, or if dryness is interfering with your ability to wear contact lenses comfortably. Symptoms that worsen in dry or windy environments, or after extended screen use, are also common indicators of meibomian gland dysfunction that responds well to the newer in-office treatments.
Persistent dryness, burning, or blurred vision are signs that warrant professional evaluation — our eye conditions we treat page outlines the full range of conditions managed at Arizona's Vision Eye Care Center, helping you understand when symptoms require clinical attention.
Early evaluation matters because untreated dry eye can progress. Chronic inflammation on the ocular surface can damage the corneal epithelium over time, and meibomian glands that remain blocked for extended periods can undergo permanent structural changes that reduce their ability to function.
A dry eye evaluation at Arizona's Vision Eye Care Center is a structured, diagnostic appointment — not simply a routine eye exam. Your provider will review your symptom history, current medications (many of which contribute to dry eye), and any previous treatments you have tried.
Diagnostic testing will assess your tear film quality, tear production volume, and the health of your meibomian glands. Meibography, when available, provides direct imaging of the gland structure and can identify atrophy or dropout that explains why symptoms have been difficult to control.
Based on your results, your provider will explain which treatment options are appropriate for your condition, what the expected timeline for improvement looks like, and how to monitor your response. For patients who wear contact lenses, your evaluation will also address lens compatibility — our contact lenses for dry eyes page explains which lens types and care routines work best for dry eye patients.
Understanding which provider manages your dry eye care is an important part of your evaluation — our optometrist vs ophthalmologist guide explains the difference in roles and helps you know what level of care your condition requires.
Dry eye disease is no longer a condition patients simply have to live with. Advances in IPL therapy, thermal pulsation, neurostimulation, and prescription biologics have created a new standard of care that addresses the root causes of chronic dry eye rather than masking symptoms.
The right treatment depends on your specific diagnosis — the type of dry eye, the degree of gland dysfunction, and how your ocular surface has responded to previous care.
At Arizona's Vision Eye Care Center in Phoenix, our team is ready to evaluate your symptoms, identify the underlying cause, and guide you toward the treatment that gives you the best chance of lasting relief. Contact us today to schedule your dry eye evaluation.
IPL therapy for dry eyes is generally considered an elective procedure and is not covered by most insurance plans. Costs vary by provider and the number of sessions required. Your eye doctor can provide a cost estimate during your evaluation.
Results vary by treatment type. Prescription drops such as cyclosporine may take 3–6 months to show full effect. In-office procedures like LipiFlow and IPL often produce noticeable improvement within 4–8 weeks after the initial treatment series is complete.
Dry eye disease is typically a chronic condition that requires ongoing management rather than a one-time cure. However, newer treatments can significantly reduce symptoms and slow disease progression, allowing many patients to achieve long-term comfort with periodic maintenance care.
FDA-cleared devices such as LipiFlow and IPL systems approved for dry eye use have established safety profiles supported by clinical studies. Prescription medications are monitored by your eye doctor for effectiveness and tolerability. Your provider will review your candidacy before recommending any treatment.
Artificial tears provide temporary surface lubrication but do not address the underlying cause of dry eye. Prescription treatments such as cyclosporine drops or in-office procedures target the inflammation or gland dysfunction driving the condition, offering longer-lasting improvement for patients with moderate to severe disease.
Yes. Dry eye can affect children, particularly those with high screen time, allergies, or certain medical conditions. If your child complains of eye irritation, frequent blinking, or difficulty with reading or screen use, a pediatric eye evaluation is recommended.
In most cases, you do not need a referral to schedule a dry eye evaluation with an optometrist. Arizona's Vision Eye Care Center accepts patients directly. If your condition requires surgical intervention or specialty care, your optometrist will coordinate a referral to an ophthalmologist.